RY 132.725 0.6178% TD 80.87 0.6848% SHOP 101.81 -0.2645% CNR 176.79 1.446% ENB 47.115 0.2874% CP 115.81 0.4162% BMO 128.39 0.8166% TRI 213.8 0.8966% CNQ 89.62 1.9568% BN 55.37 2.613% ATD 86.4 2.0553% CSU 3732.3201 1.8791% BNS 64.09 0.2973% CM 63.17 0.9912% SU 45.295 -0.1213% TRP 53.81 -0.0186% NGT 41.83 -7.2506% WCN 230.18 1.8811% MFC 32.78 1.1416% BCE 50.78 -0.8203%

Aurora Cannabis Inc

Healthcare CA ACB


Last update at 2024-02-22T19:36:00Z

Day Range


52 Week Range



Income Statement


Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -221.53200M -1720.12000M -699.79800M -3383.89600M -328.23100M
Minority interest - 0.35M 1.46M -24.35600M 4.41M
Net income -198.99700M -1717.97900M -693.47700M -3300.49300M -297.92400M
Selling general administrative 133.40M 126.97M 139.68M 265.18M 279.40M
Selling and marketing expenses - 62.02M 55.20M 91.27M 99.29M
Gross profit -33.35400M 21.23M -21.55800M -33.53900M 159.81M
Reconciled depreciation - 93.66M 98.08M 114.89M 88.26M
Ebit - -219.37500M -282.81800M -490.96200M -297.02700M
Ebitda - -143.08900M -137.20000M -393.23100M -214.66200M
Depreciation and amortization - 76.29M 145.62M 97.73M 82.36M
Non operating income net other - - - - -
Operating income -220.67800M -219.37500M -282.81800M -490.96200M -297.02700M
Other operating expenses - 440.71M 491.90M 763.38M 544.97M
Interest expense - 71.81M 66.44M 77.54M 41.02M
Tax provision -15.23700M -2.14100M -6.32100M -83.40300M -29.90900M
Interest income 2.53M 4.51M 72.67M 56.59M 70.89M
Net interest income - -67.30600M -60.69200M -72.54800M -37.34600M
Extraordinary items - 0.00000M -1.61200M -9.84400M 0.14M
Non recurring - - - - -
Other items - - - - -
Income tax expense - -2.14100M -6.32100M -83.40300M -30.30700M
Total revenue 174.97M 221.34M 245.25M 278.91M 247.94M
Total operating expenses - 240.60M 225.09M 450.93M 456.84M
Cost of revenue 208.32M 200.11M 266.81M 312.44M 88.12M
Total other income expense net - -1500.74500M -416.98000M -2892.93400M -31.20400M
Discontinued operations - - -1.61200M -9.84400M 0.14M
Net income from continuing ops - -1717.97900M -693.47700M -3300.49300M -297.92400M
Net income applicable to common shares -198.99700M -1717.62400M -693.62500M -3283.67100M -293.50900M
Preferred stock and other adjustments - - - - -
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Total assets 926.32M 1084.36M 2604.73M 2783.70M 5502.83M
Intangible assets 59.68M 70.70M 367.45M 412.27M 688.37M
Earning assets - - - - -
Other current assets 66.54M 119.01M 46.48M 40.12M 51.84M
Total liab 440.25M 422.00M 567.03M 657.25M 1112.78M
Total stockholder equity 486.08M 661.84M 2037.70M 2150.81M 4385.64M
Deferred long term liab - - - - -
Other current liab - 94.52M 57.99M 42.18M 293.10M
Common stock 6841.23M 6754.63M 6424.30M 5785.40M 4673.12M
Capital stock - 6754.63M 6424.30M 5785.40M 4673.12M
Retained earnings -6056.41200M -6038.27500M -4321.08500M -3592.78700M -283.63800M
Other liab - 40.29M 92.04M 5.81M 280.34M
Good will 18.71M 0.00000M 887.74M 928.43M 3172.55M
Other assets 38.53M 33.87M 77.27M 57.76M 93.33M
Cash - 437.81M 421.46M 162.18M 172.73M
Cash and equivalents 234.94M 437.81M 421.46M 162.18M 172.73M
Total current liabilities 242.31M 145.23M 116.38M 272.81M 436.37M
Current deferred revenue - 3.85M 4.17M 3.52M 1.48M
Net debt - -168.31600M -21.90700M 369.07M 472.10M
Short term debt 0.00000M 33.00M 40.94M 152.62M 249.67M
Short long term debt - 26.85M 34.75M 152.62M 249.67M
Short long term debt total - 269.49M 399.55M 531.25M 644.83M
Other stockholder equity -298.74600M -54.50800M -65.51100M -41.80200M -3.84300M
Property plant equipment 322.97M 230.30M 598.28M 928.23M 750.08M
Total current assets 479.93M 745.12M 665.89M 420.74M 664.17M
Long term investments - 1.21M 0.29M 18.11M 118.84M
Net tangible assets - 587.99M 774.70M 791.96M 506.56M
Short term investments 0.00000M 1.33M 3.75M 7.07M 143.25M
Net receivables 35.02M 47.05M 56.48M 54.11M 112.33M
Long term debt 36.16M 199.65M 293.18M 294.93M 394.19M
Inventory 128.82M 139.93M 137.72M 157.26M 165.48M
Accounts payable - 13.86M 13.28M 95.57M 38.67M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - -54.50800M -65.51100M -41.80200M -3.84300M
Additional paid in capital - - - - -
Common stock total equity - - - 5785.40M 4673.12M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - 33.87M 77.27M 57.76M 93.33M
Deferred long term asset charges - - - - -
Non current assets total - 339.24M 1938.84M 2362.96M 4838.66M
Capital lease obligations - 42.99M 71.62M - -
Long term debt total 79.97M 236.49M 358.61M 378.63M 395.16M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments - -36.60000M 18.06M -249.48300M -312.29700M
Change to liabilities - 3.31M -28.08000M -19.34300M 98.98M
Total cashflows from investing activities -27.29100M -36.60000M -26.90500M -249.48300M -312.29700M
Net borrowings - -170.83100M -122.92000M -38.83000M 583.74M
Total cash from financing activities -71.40600M 147.78M 521.95M 582.56M 597.55M
Change to operating activities - 6.47M 12.64M -2.45200M -11.02900M
Net income -206.29500M -1717.97900M -693.47700M -3300.49300M -297.92400M
Change in cash -202.86500M 16.35M 259.28M -10.54800M 95.94M
Begin period cash flow 437.81M 421.46M 162.18M 172.73M 76.78M
End period cash flow - 437.81M 421.46M 162.18M 172.73M
Total cash from operating activities -115.82100M -109.83800M -210.57700M -337.95200M -192.24500M
Issuance of capital stock - 350.19M 666.03M 575.51M 59.33M
Depreciation 31.99M 93.66M 98.08M 114.89M 88.26M
Other cashflows from investing activities -15.15900M -0.18500M -4.67500M -9.30300M -5.56100M
Dividends paid - - - - -
Change to inventory - 21.07M 8.45M -29.39000M -50.28400M
Change to account receivables - 18.76M 7.37M 55.46M -57.16100M
Sale purchase of stock 73.19M 350.19M 666.03M 575.51M 59.33M
Other cashflows from financing activities -14.92800M -31.57800M -21.15200M 132.28M 559.58M
Change to netincome - 1464.18M 384.57M 2823.18M 50.29M
Capital expenditures 12.13M 32.21M 53.08M 355.01M 414.30M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -25.11600M 49.95M 0.40M 7.64M -37.95200M
Stock based compensation - 13.76M 20.24M 59.90M 107.04M
Other non cash items - 1452.97M 370.63M 2858.41M -28.41000M
Free cash flow - -142.05100M -263.65900M -692.95800M -606.54300M


  • Previous Close 4.55
  • Market Cap261.28M
  • Volume420565
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-143.76000M
  • Revenue TTM225.18M
  • Revenue Per Share TTM0.74
  • Gross Profit TTM 21.23M
  • Diluted EPS TTM-7.92

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
Aurora Cannabis Inc
-0.21 4.62% 4.34 - - 1.16 0.53 1.25 -0.1613
Bausch Health Companies Inc
0.88 7.53% 12.57 - 2.10 0.47 18.74 3.89 18.18
Tilray Inc
-0.02 0.82% 2.41 - 1000.00 2.91 0.45 3.43 -1.9457
Cronos Group Inc
0.03 1.00% 3.02 - - 11.24 0.67 0.07 1.02
TerrAscend Corp.
0.06 2.75% 2.24 - - - -

Reports Covered

Stock Research & News


Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Aurora Cannabis Inc

500 - 10355 Jasper Avenue, Edmonton, AB, Canada, T5J 1Y6

Key Executives

Name Title Year Born
Mr. Miguel Martin CEO & Director 1972
Mr. Glen Ibbott Chief Financial Officer NA
Mr. Alex Miller Exec. VP of Operations & Supply Chain NA
Ms. Lori Schick Exec. VP of HR NA
Mr. Andre Jerome Exec. VP of Global Bus. Devel. NA
Ananth Krishnan VP of Capital Markets & Investor Relations NA
Mr. Nathalie Clark Exec. VP, Gen. Counsel & Corp. Sec. NA
Michelle Lefler VP of Communications & PR NA
Mr. Carey Squires Exec. VP of Corp. Devel. & Strategy NA
Mr. John Barnet Chief Cultivator NA

Disclaimer - Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peer trades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).